Mavrogenis A F, Mitsiokapa E A, Sakellariou V I, Tzanos G, Papagelopoulos P J
First Department of Orthopaedics, "Attikon" University Hospital, Athens University Medical School, Athens, Greece.
J BUON. 2011 Apr-Jun;16(2):353-60.
To report the clinical and radiological outcome of limb salvage surgery with the STANMORE megaprostheses.
We retrospectively studied 33 patients with musculoskeletal tumor limb salvage surgery using STANMORE megaprostheses. Clinical evaluation was done using the Enneking and the Toronto Extremity Salvage Score (TESS). Radiographic evaluation was done using the International Society of Limb Salvage (ISOLS) score.
At a mean follow-up of 18 months, 21 patients were alive with no evidence of disease and two patients were alive with metastatic disease; 9 patients died of metastatic disease and one patient of causes unrelated to the primary tumor. Local recurrence was not observed in any of the patients. The mean Enneking and TESS scores were 76 and 88.4%, respectively. The ISOLS score was excellent or good in 30 cases for bone remodelling, 30 cases for the interface, in 30 cases for anchorage, in 32 cases for the implant body, and in 33 cases for the articulation. Extracortical bone bridging greater than 25% was observed in 8 prostheses. Mechanical survival of the megaprostheses was 97% (32 megaprostheses). Complications included seroma and hematoma formation (12%), skin necrosis and dehiscence at the knee wound (9%), aseptic loosening and infection (6%), quadriceps tendon rupture and peroneal nerve palsy (3%).
The local recurrence-free survival in this series supports limb salvage surgery. The 97% survival rate of the megaprostheses suggests that the STANMORE modular megaprostheses are valuable for reconstruction of bone defects after tumor resection.
报告使用STANMORE大型假体进行保肢手术的临床和放射学结果。
我们回顾性研究了33例使用STANMORE大型假体进行肌肉骨骼肿瘤保肢手术的患者。使用Enneking评分和多伦多肢体挽救评分(TESS)进行临床评估。使用国际肢体挽救协会(ISOLS)评分进行放射学评估。
平均随访18个月时,21例患者存活且无疾病证据,2例患者存活但有转移性疾病;9例患者死于转移性疾病,1例患者死于与原发肿瘤无关的原因。所有患者均未观察到局部复发。Enneking评分和TESS评分的平均值分别为76分和88.4%。在30例患者中,ISOLS评分在骨重塑、界面、固定、植入体和关节方面为优秀或良好。8个假体观察到皮质外骨桥接大于25%。大型假体的机械存活率为97%(32个大型假体)。并发症包括血清肿和血肿形成(12%)、膝关节伤口皮肤坏死和裂开(9%)、无菌性松动和感染(6%)、股四头肌肌腱断裂和腓总神经麻痹(3%)。
本系列中无局部复发的生存率支持保肢手术。大型假体97%的存活率表明STANMORE模块化大型假体对肿瘤切除后骨缺损的重建有价值。